Aimei Health Technology Co. Ltd. has extended the period to consummate its initial business combination by one month, from December 6, 2025 to January 6, 2026, by depositing $34,330.96 into its trust account for public shareholders. To fund this extension, the company issued an unsecured promissory note totaling $34,330.96, equally divided between Aimei Health Ltd. and United Hydrogen Group Inc. The note, issued on December 5, 2025, bears no interest and is payable upon the completion of the business combination with United Hydrogen. The lenders have the option to convert the note into private units of Aimei Health Technology Co. Ltd. at a price of $10.00 per unit prior to the deal's closing.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aimei Health Technology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-026631), on December 08, 2025, and is solely responsible for the information contained therein.
Comments